中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2013年
14期
114-115
,共2页
异位妊娠%相关病因%特点%分析%探讨
異位妊娠%相關病因%特點%分析%探討
이위임신%상관병인%특점%분석%탐토
Ectopic pregnancy%Related causes of disease%Characteristics%Analysis%Discussion
目的:分析探讨异位妊娠的相关病因及其特点,为早期诊断、治疗及预防提供依据.方法:采用回顾性分析方法,分析探讨本院2008年8月-2012年8月收治的803例异位妊娠患者相关病因及其特点.结果:803例中慢性盆腔炎占33.1%,流产史23%,盆腔手术史占20.8%,重复异位妊娠占9.7%,宫内节育器占5%,辅助生殖技术后占2.9%,药物紧急避孕占1.9%,剖宫产后占1.6%,正常分娩后占0.6%,其它原因占1.4%.结论:异位妊娠与慢性盆腔炎史,流产史(包括药物流产、人工流产),盆腔手术史、重复异位妊娠等多种因素密切相关.对这些因素加以预防,有助于降低该病的发病率.
目的:分析探討異位妊娠的相關病因及其特點,為早期診斷、治療及預防提供依據.方法:採用迴顧性分析方法,分析探討本院2008年8月-2012年8月收治的803例異位妊娠患者相關病因及其特點.結果:803例中慢性盆腔炎佔33.1%,流產史23%,盆腔手術史佔20.8%,重複異位妊娠佔9.7%,宮內節育器佔5%,輔助生殖技術後佔2.9%,藥物緊急避孕佔1.9%,剖宮產後佔1.6%,正常分娩後佔0.6%,其它原因佔1.4%.結論:異位妊娠與慢性盆腔炎史,流產史(包括藥物流產、人工流產),盆腔手術史、重複異位妊娠等多種因素密切相關.對這些因素加以預防,有助于降低該病的髮病率.
목적:분석탐토이위임신적상관병인급기특점,위조기진단、치료급예방제공의거.방법:채용회고성분석방법,분석탐토본원2008년8월-2012년8월수치적803례이위임신환자상관병인급기특점.결과:803례중만성분강염점33.1%,유산사23%,분강수술사점20.8%,중복이위임신점9.7%,궁내절육기점5%,보조생식기술후점2.9%,약물긴급피잉점1.9%,부궁산후점1.6%,정상분면후점0.6%,기타원인점1.4%.결론:이위임신여만성분강염사,유산사(포괄약물유산、인공유산),분강수술사、중복이위임신등다충인소밀절상관.대저사인소가이예방,유조우강저해병적발병솔.
Objective:To analyze and discuss related causes and characteristics of ectopic pregnancy and provide basis for its early diagnosis, therapy and prevention. Method:Retrospective analysis method was used to analyze and discuss related causes and characteristics of 803 patients of ectopic pregnancy admitted by our hospital from August 2008 to August 2012. Result:Among these 803 patients,chronic pelvic inflammation accounted for 33.1%,abortion history 23%,pelvic cavity surgery history 20.8%,recurrent ectopic pregnancy 9.7%,intrauterine device 5%,assisted reproductive technology 2.9%,emergency contraception by drug 1.9%,cesarean delivery 1.6%,normal labor 0.6%and other causes 1.4%. Conclusion:Ectopic pregnancy is closely related to many factors such as chronic pelvic inflammation,abortion history(including medical abortion and artificial abortion), pelvic cavity surgery and recurrent ectopic pregnancy. The prevention on these factors is conducive to the decrease of morbidity of this disease.